Titre:
  • Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: Perhaps some potential confounders to consider
Auteur:Honoré, Patrick P.M.; Gutierrez, Leonel Barreto; Kugener, Luc; Redant, Sébastien; Attou, Rachid; Gallerani, Andrea; De Bels, David
Informations sur la publication:Critical care, 24, 1, 603
Statut de publication:Publié, 2020-10
Sujet CREF:Généralités
Note générale:SCOPUS: le.j
Langue:Anglais
Identificateurs:urn:issn:1364-8535
info:doi/10.1186/s13054-020-03294-7
info:scp/85092456507
info:pmid/33036639